Aspen has entered into a preliminary agreement to manufacture Johnson & Johnson’s COVID-19 vaccine candidate, if it does become successful. The vaccine candidate is currently undergoing clinical trials. Stavros Nicolaou, Senior Executive for Strategic Trade at Aspen joins CNBC Africa for more.